Definition and Localization
In pharmacology and clinical medicine, drug-induced dysbiosis refers to a pronounced disturbance in the normal, evolutionarily established balance of the microflora (microbiota). This pathological process develops primarily on the surface of mucous membranes that are normally densely colonized by beneficial microorganisms.
Key anatomical sites where dysbiosis manifests most prominently:
- Mucous membrane of the gastrointestinal tract (GI tract).
- Oral mucosa.
- Vaginal mucosa.
It is in these zones that the resident microflora performs critical protective functions, the loss of which leads to serious clinical consequences.
Etiology: Causes of the Imbalance
From an etiological standpoint, the development of this adverse effect is directly linked to ongoing pharmacotherapy. Most commonly, the trigger is the administration of antimicrobial agents.
Broad-spectrum antibiotics pose the greatest threat to the natural balance of the microbiota. Unlike narrow-spectrum agents, they lack high selectivity and exert a detrimental effect not only on the target pathogen, but also on the patient's commensal (normal) flora.
Pathogenesis of Drug-Induced Dysbiosis
The mechanism of development (pathogenesis) of dysbiosis during antibacterial therapy represents a sequential cascade of disorders that can be divided into three key stages:
- Destruction of beneficial flora. Under the direct pharmacological action of the antibiotic, massive death of beneficial microflora occurs, which normally competes for nutrients and receptors on the mucous membranes.
- Suppression of host defenses. The loss of normal microbiota inevitably leads to a reduction in mucosal local immunity, as beneficial bacteria play a critical role in maintaining it.
- Opportunistic infection. In the absence of competition and diminished immune surveillance, active and uncontrolled proliferation of opportunistic microflora begins. Specifically, vacant ecological niches are rapidly colonized by yeast-like fungi of the genus Candida.
Treatment and Prevention
To minimize the consequences of antibiotic therapy and eliminate established dysbiosis, a comprehensive approach comprising two main directions is used:
Etiotropic Therapy Aiming to suppress the proliferated opportunistic flora, primarily fungal organisms. For this purpose, antifungal agents are prescribed, often concurrently with a course of antibiotics. A classic example of such a drug is nystatin.
Restoration of Normal Flora After suppressing the pathogens, it is necessary to artificially replenish the deficiency of beneficial bacteria on the mucous membranes. Specialized preparations containing lyophilized (specially freeze-dried) live bacteria are used for this purpose. The most well-known representatives of this group include:
- Bifidobacterium preparations (e.g., Bifidobacterium bifidum)
- Combined probiotic formulas